Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma

被引:47
作者
Fosse, E [1 ]
Pillgram-Larsen, J [1 ]
Svennevig, JL [1 ]
Nordby, C [1 ]
Skulberg, A [1 ]
Mollnes, TE [1 ]
Abdelnoor, M [1 ]
机构
[1] Ulleval Hosp, Dept Surg, Oslo, Norway
来源
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED | 1998年 / 29卷 / 07期
关键词
D O I
10.1016/S0020-1383(98)00113-2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In order to study the factors related to complement activation, the complement activation products C3bc and TCC were measured in plasma at admittance and during the stay in the intensive cave unit in 108 consecutive patients with multiple injuries. These patients were admitted to the surgical department during a 4-month period. Complement activation occurred immediately after the trauma and correlated strongly with the Injury Severity Score and was inversely correlated to the Base Excess. Complement activation also correlated with the number of transfusions. Sepsis caused complement activation later during the stay in hospital. All seven patients developing the adult respiratory distress syndrome (ARDS) had increased complement activation, either on admission or later during the stay in the intensive care unit. Complement activation is known to contribute to organ damage following ischemia and reperfusion. Clinical studies have demonstrated the importance of early restoration of adequate circulation and the present demonstration of a strong negative correlation between complement activation and Base Excess indicates that early restoration of aerobic metabolism may reduce complement activation and the risk for organ dysfunction. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:509 / 514
页数:6
相关论文
共 35 条
  • [1] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [2] BOUYER J, 1992, EPIDEMIOLOGIE EXPLIC
  • [3] EVALUATING TRAUMA CARE - THE TRISS METHOD
    BOYD, CR
    TOLSON, MA
    COPES, WS
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1987, 27 (04) : 370 - 378
  • [4] COMPLEMENT ACTIVATION AND ENDOTOXIN LEVELS IN SYSTEMIC MENINGOCOCCAL DISEASE
    BRANDTZAEG, P
    MOLLNES, TE
    KIERULF, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (01) : 58 - 65
  • [5] TRAUMA SCORE
    CHAMPION, HR
    SACCO, WJ
    CARNAZZO, AJ
    COPES, W
    FOUTY, WJ
    [J]. CRITICAL CARE MEDICINE, 1981, 9 (09) : 672 - 676
  • [6] *COMM INJ SCAL, 1990, ABBR INJ SCAL 1990 R
  • [7] DALY LE, 1991, INTERPRETATION USES, P157
  • [8] FOSSE E, 1987, J THORAC CARDIOV SUR, V93, P860
  • [9] FOSSE E, 1987, ACTA CHIR SCAND, V153, P325
  • [10] QUANTIFICATION IN ENZYME-LINKED IMMUNOSORBENT-ASSAY OF A C-3 NEOEPITOPE EXPRESSED ON ACTIVATED HUMAN-COMPLEMENT FACTOR-C3
    GARRED, P
    MOLLNES, TE
    LEA, T
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 27 (03) : 329 - 335